News
ImmuCell Appoints Two New Members to its Board of Directors
PORTLAND, Maine, Jan. 30, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Corporation Announces Closing of $3 Million Public Offering of Common Stock
PORTLAND, Maine, Dec. 21, 2017 -- ImmuCell Corporation ("ImmuCell" or the "Company") (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Corporation Announces Pricing of $3 Million Public Offering of Common Shares
PORTLAND, Maine, Dec. 19, 2017 -- ImmuCell Corporation ("ImmuCell" or the "Company") (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Financial Results for Third Quarter of 2017
PORTLAND, Maine, Nov. 13, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and productivity of dairy and beef cattle, today announced unaudited...
ImmuCell Achieves USDA Approval of New Product Claim to Prevent Rotavirus Infections
PORTLAND, Maine, Nov. 13, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and productivity of dairy and beef cattle, today announced that the...
ImmuCell Announces Completion of Construction of Nisin Production Facility
PORTLAND, Maine, Nov. 07, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and productivity of dairy and beef cattle, today announced completion...
ImmuCell to Announce Financial Results for Third Quarter of 2017
Conference Call Scheduled for Monday, November 13, 2017 at 4:30 PM ET PORTLAND, Maine, Nov. 02, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health...
ImmuCell Announces Expansion of Sales and Marketing Team
PORTLAND, Maine, Sept. 13, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve health and productivity in the dairy and beef industries, today announced the...
ImmuCell Announces Financial Results for Second Quarter of 2017
PORTLAND, Maine, Aug. 14, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve health and productivity in the dairy and beef industries, today announced...
ImmuCell to Announce Financial Results for Second Quarter of 2017
Conference Call Scheduled for Monday, August 14, 2017 at 4:30 PM ET PORTLAND, Maine, Aug. 07, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve animal health...